Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-025191
Filing Date
2013-05-03
Accepted
2013-05-03 17:31:41
Documents
1
Period of Report
2013-04-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd378411.html 4/A  
1 FORM 4/A rrd378411.xml 4/A 3947
  Complete submission text file 0001181431-13-025191.txt   5320
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Dorman H. Paul (Reporting) CIK: 0001575028 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-54910 | Film No.: 13813931